Search
for
Sort by
Research 61–90 of 118
- Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Anticancer effects of metformin on neuroendocrine tumor cells in vitro
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Challenges in the Physical Characterization of Lipid Nanoparticles
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Assessing the cost-effectiveness of DNA origami nanostructures for targeted delivery of anti-cancer drugs to tumours
- Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Effective treatment of intractable diseases using nanoparticles to interfere with vascular supply and angiogenic process
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Effects of mitotane treatment on human steroid metabolism: implications for patient management
- Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- Prophylaxis and Management of Skin Toxicities
- Sorafenib-Associated Facial Acneiform Eruption
- Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
- Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing